{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:26:36Z","timestamp":1788852396999,"version":"build-2803163510"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,24]]},"abstract":"<jats:title>Vignette<\/jats:title>\n               <jats:p>A 10-year-old girl developed bilateral gonalgia and waddling gait. Biochemical and imaging studies showed hypophosphatemia with impaired proximal tubular phosphate reabsorption and high intact fibroblast growth factor 23 (FGF23) level, indicating FGF23-related hypophosphatemic rickets\/osteomalacia. However, genetic analyses for hereditary FGF23-related hypophosphatemic rickets were negative. 111In-pentetreotide scintigraphy and 18F-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography (PET\/CT) which were available at that time, failed to find a tumor associated with tumor-induced rickets\/osteomalacia. She was first treated with active vitamin D and phosphate salt, followed by burosumab which alleviated her symptoms. She was then referred to our hospital to find the cause of her disease, and the previous imaging results were reevaluated. There was an asymmetrical uptake in the distal portion of her right femur by PET\/CT. The following magnetic resonance imaging confirmed the presence of a tumor in the lateral portion of the right femur. Wide excision of the lesion corrected hypophosphatemia. The differential diagnoses and treatment of hypophosphatemic rickets\/osteomalacia are discussed.<\/jats:p>","DOI":"10.1093\/jbmr\/zjaf047","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T17:12:56Z","timestamp":1743354776000},"page":"572-576","source":"Crossref","is-referenced-by-count":3,"title":["Tumor-induced rickets\/osteomalacia (TIO): diagnostic pitfalls and therapeutic options"],"prefix":"10.1093","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4071-5372","authenticated-orcid":false,"given":"Nobuaki","family":"Ito","sequence":"first","affiliation":[{"name":"Division of Therapeutic Development for Intractable Bone Diseases, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3610-3469","authenticated-orcid":false,"given":"Seiji","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Tamaki-Aozora Hospital , Tokushima 779-3125,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"issue":"8","key":"2025052505463512300_ref1","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1002\/jbmr.4620","article-title":"Clinical challenges in diagnosis, tumor localization and treatment of tumor-induced osteomalacia: outcome of a retrospective surveillance","volume":"37","author":"Hidaka","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2025052505463512300_ref2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/jbmr.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2025052505463512300_ref3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000357142","article-title":"Serum fibroblast growth factor 23 is a useful marker to distinguish vitamin D-deficient rickets from hypophosphatemic rickets","volume":"81","author":"Kubota","year":"2014","journal-title":"Horm Res Paediatr"},{"issue":"10","key":"2025052505463512300_ref4","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1210\/jcem.83.10.5167","article-title":"A PHEX gene mutation is responsible for adult-onset vitamin D-resistant hypophosphatemic osteomalacia: evidence that the disorder is not a distinct entity from X-linked hypophosphatemic rickets","volume":"83","author":"Econs","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025052505463512300_ref5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMc2405746","article-title":"Acquired Osteomalacia associated with autoantibodies against PHEX","volume":"392","author":"Hoshino","year":"2025","journal-title":"N Engl J Med"},{"issue":"2","key":"2025052505463512300_ref6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1210\/endrev\/bnac026","article-title":"Tumor-induced Osteomalacia: a comprehensive review","volume":"44","author":"Minisola","year":"2023","journal-title":"Endocr Rev"},{"issue":"4","key":"2025052505463512300_ref7","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/j.1365-2796.2010.02262.x","article-title":"Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia","volume":"268","author":"Ito","year":"2010","journal-title":"J Intern Med"},{"issue":"23","key":"2025052505463512300_ref8","doi-asserted-by":"publisher","first-page":"11418","DOI":"10.1073\/pnas.1815166116","article-title":"Activation of unliganded FGF receptor by extracellular phosphate potentiates proteolytic protection of FGF23 by its O-glycosylation","volume":"116","author":"Takashi","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2025052505463512300_ref9","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1172\/jci122004","article-title":"Autoimmune hyperphosphatemic tumoral calcinosis in a patient with FGF23 autoantibodies","volume":"128","author":"Roberts","year":"2018","journal-title":"J Clin Invest"},{"issue":"7","key":"2025052505463512300_ref10","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician's guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter TO","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2025052505463512300_ref11","doi-asserted-by":"publisher","first-page":"100266","DOI":"10.1016\/j.modpat.2023.100266","article-title":"RNA sequencing reveals novel oncogenic fusions and depicts detailed fusion transcripts of FN1-FGFR1 in phosphaturic mesenchymal tumors","volume":"36","author":"Liu","year":"2023","journal-title":"Mod Pathol"},{"issue":"8","key":"2025052505463512300_ref12","doi-asserted-by":"publisher","first-page":"e10661","DOI":"10.1002\/jbm4.10661","article-title":"Infigratinib reduces fibroblast growth factor 23 (FGF23) and increases blood phosphate in tumor-induced Osteomalacia","volume":"6","author":"Hartley","year":"2022","journal-title":"JBMR Plus"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjaf047\/62802231\/zjaf047.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/40\/5\/572\/62802231\/zjaf047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/40\/5\/572\/62802231\/zjaf047.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T09:46:43Z","timestamp":1748166403000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/40\/5\/572\/8099488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":12,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3,28]]},"published-print":{"date-parts":[[2025,5,24]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmr\/zjaf047","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,3,28]]}}}